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Abstract
Background: Breastfeeding protects against illnesses and death in hazardous environments, an effect partly mediated by
improved immune function. One hypothesis suggests that factors within milk supplement the inadequate immune
response of the offspring, but this has not been able to account for a series of observations showing that factors within
maternally derived milk may supplement the development of the immune system through a direct effect on the primary
lymphoid organs. In a previous human study we reported evidence suggesting a link between IL-7 in breast milk and the
thymic output of infants. Here we report evidence in mice of direct action of maternally-derived IL-7 on T cell development
in the offspring.
Methods and Findings: We have used recombinant IL-7 labelled with a fluorescent dye to trace the movement in live mice
of IL-7 from the stomach across the gut and into the lymphoid tissues. To validate the functional ability of maternally
derived IL-7 we cross fostered IL-7 knock-out mice onto normal wild type mothers. Subsets of thymocytes and populations
of peripheral T cells were significantly higher than those found in knock-out mice receiving milk from IL-7 knock-out
mothers.
Conclusions/Significance: Our study provides direct evidence that interleukin 7, a factor which is critical in the
development of T lymphocytes, when maternally derived can transfer across the intestine of the offspring, increase T cell
production in the thymus and support the survival of T cells in the peripheral secondary lymphoid tissue.
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Introduction
Breastfeeding, according to the World Health Organisation is
an unequalled way of providing ideal food for the healthy
growth and development of infants; who should be exclusively
breastfed for the first six months of life [1]. Epidemiologic
studies in low income countries show that breast feeding
substantially reduces the risk of infection, especially from enteric
disease [2,3] and that lactation represents an ‘ingenious
immunological integration of the mother and the child’ [2].
Breast milk is also a vehicle for providing immunological
support to the developing offspring with the well demonstrated
presence of the products of both cellular and humoral immune
responses in breast milk following vaccination of the mother
[4,5,6,7,8,9,10,11].
The reduction in the severity and frequency of disease in breast-
fed infants indicates the impact of components of breast milk on
immunity in the offspring, but at issue is whether this protection
arises solely through factors in the milk supplementing the
inadequate immune response of the offspring or whether
components within milk have a dichotomic effect both supple-
menting the response and enhancing the development of the
immune system, boosting the production and aiding the survival of
lymphocytes, in the offspring.
Supplementation of the immune response of the offspring is the
current paradigm for characterising the beneficial action of
breastfeeding with evidence presented for factors transmitted to
the offspring acting directly on the potential pathogen. For
example IgA antibodies specific for E. coli, H. influenzae, H. pylori
and S. pneumoniae which have been found in human milk and which
act in the intestinal lumen (or in the airways following inhalation of
milk droplets) of the offspring by binding antigen, so reducing the
infective nature of potential pathogens. In addition factors such as
epidermal growth factor may help to induce more rapid
maturation of the intestinal epithelium leading to decreased
permeability to pathogens [12].
Less direct evidence is available to support the notion that
breast milk factors enhance the development of the immune
system within the offspring. Whilst the link between inadequate
nutrition and thymic atrophy has been known since at least 1810
[13] it was only more recently shown that offspring fed on breast
milk possessed larger thymuses than those fed on formula feed
[14,15] suggesting the presence of a component in breast milk
which could augment thymic growth and development. Thymic
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size is important, partly because in humans a small thymic size at 6
months of age is associated with a higher risk of mortality [16] and
partly because thymic size is also an indicator of thymic output
[17]. A positive correlation between thymic size in the perinatal
period and survival was also shown by a study in Guinea-Bissau
[18] and later extended by work in rural Gambia [19].
Studies in rural Gambia showed that children born in the
hungry season have smaller thymuses eight weeks after birth
compared with their counterparts born in the harvest season
[19,20]. Moreover the rates of mortality in young adulthood of
those born before the harvest were up to 10-fold higher than their
counterparts, with the available data suggesting many of the
deaths were infection-related [21,22]. One factor considered
integral to the concept of enhancing immune development was
interleukin-7 (IL-7) shown to be present at higher levels in the
breast milk of those born after the harvest in the rural Gambian
study [19]. IL-7 has a central role in T cell development in the
thymus and the maintenance of T cells in the peripheral T cell
pool [23]. Because of the association between the amount of
available IL-7 in the thymus and thymocyte numbers [24], the
possibility that maternally-derived IL-7 was having an additive
effect on thymic output in the offspring has been proposed [19].
However this would require that the IL-7 survive digestion and be
transmitted from the mother to the tissues of the offspring through
the medium of the maternally derived milk.
We sought to test this possibility by feeding newborn mouse
pups recombinant IL-7, labelled with a fluorescent dye, and
tracing its path within the animal. To supplement these studies we
also sought to determine the effect of cross fostering newborn
transgenic mouse pups carrying the IL-7 knock out gene onto wild
type dams to determine whether there was an effect of the murine
maternally derived IL-7.
Methods
Ethics statement
All mice were housed in the animal house at Imperial College
London and all experiments were carried out under approval by
the Home Office under Project License (PPL70/5736). All efforts
were made to minimise pain and suffering. No human samples
were used in this study.
Mice
Wild type C57Bl/6 mice were purchased from Harlan Olac and
maintained either in positive pressure isolators or individually
ventilated cages. For feeding experiments most mice were born at
night and so the day of their first appearance was considered to be
day 1. IL-7 knock-out mice were obtained from the National
Institute of Medical Research with the permission of Prof. Paulo
Viera and maintained in positive pressure isolators. These mice were
originally generated from mutated ES cells injected into blastocysts
from C57BL/6 mice, where the resulting male chimeras were mated
to C57BL/6 females to test for germ-line transmission [25].
Analysis of IL-7 levels in milk
Sucking pups were culled by cervical dislocation, their stomachs
removed and the wall dissected away from the bolus of milk. The
partially solidified milk was resuspended in phosphate buffered saline
overnight at 4uC and the IL-7 content was assayed by sandwich ELISA
and quantified against recombinant murine IL-7 standards (R&D, UK).
Cell staining and analysis
Analysis of thymocyte subsets was performed as previously
described [26]. Briefly the thymus was removed and cell
suspensions made and approximately 16106 thymocytes were
incubated with the following sets of anti-bodies; anti-CD4-R-PE
(clone H129.19), anti-CD8-R-PE (clone 53-6.7), anti-CD3-R-PE
(clone 17A2), anti-CD19-R-PE (clone ID3), anti-CD25-FITC
(clone 7D4) and anti-CD44-Cy-chrome (clone IM7) or their
appropriate isotype controls. Alternatively thymocytes were
stained with anti-CD8-FITC (clone 53-6.7) and anti-CD4-Cy-
Chrome (clone H129.19) or their appropriate isotype controls.
Spleens were removed and cell suspensions made and the total
number of cells obtained counted. Cells were then stained with
anti-CD8-FITC (clone 53-6.7) and anti-CD4-Cy-Chrome (clone
H129.19) and anti-CD3-R-PE (clone 17A2) or their appropriate
isotype controls. All antibodies were obtained from Becton
Dickinson.
Cells were stained with the antibody cocktails for approximately
30 minutes at 4uC and then washed with phosphate buffered saline
(PBS) and fixed with 1% paraformaldehyde in PBS. Cells were
analysed with a with a FACS Calibur flow cytometer (BD
Pharmingen) and data analysis was performed using WinMDI
software.
IRDye 800 labelling of IL-7 and tracing in vivo
Carrier-free recombinant mouse IL-7 (R&D) or carrier-free
recombinant mouse albumin (Gentaur, Brussels) were labelled
with IRDye800 (Li-cor biosciences) according to the manufactur-
er’s instructions a version of which can be found at http://
biosupport.licor.com/support. Briefly, the protein dissolved in
PBS and the reactive IRDye 800 dissolved in DMSO were mixed
in the dark for approximately 2 hours and then dialysed against
PBS. 100 ng of labelled proteins were delivered into the stomachs
of newborn mice within 24 hours of birth by gavage and the mice
were immobilised by chilling [27] and scanned using a Li-cor
Odyssey scanner.
Quantitation of labelled protein in the tissues
Tissues were digested in 50 ml of a 1 in 5 dilution of proteinase k
(Qiagen UK) in PBS overnight at 37uC. The solution was then
placed in the wells of a 96 well plate and scanned. The plate also
contained a dilution series in quadruplicate of labelled mouse IL-7.
Prior analysis revealed that overnight incubation in the presence of
proteinase K did not affect the level of fluorescence.
Figure 1. IL-7 can be detected in the milk of mice in the
offspring after birth but not for the entire period of weaning.
The IL-7 content of milk was assayed by sandwich ELISA and quantified
against recombinant murine IL-7 standards.
doi:10.1371/journal.pone.0020812.g001
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Cross fostering experiments
Breeding programs were set up with both the IL-7 knock out
and C57/Bl6 wild type animals. Litters were transferred to their
foster dams within 24 hours of birth. Animals were taken at
weaning (approximately 20 days after birth) culled by CO2
asphyxiation and their tissues removed.
Statistical analysis
Statistical analysis was performed using an unpaired T test
where significance was considered when p,0.05.
Results
IL-7 in mouse milk
We demonstrated the presence of IL-7 in mouse milk, by
assaying milk obtained from the stomachs of suckling mice at
several time points in the post natal period. Two days after birth,
mouse pups had IL-7 present at an average of 146 pg per animal
and this fell to an average of 76pg per animal 4 days after birth
Figure 2. Diagrammatic representation of an outline of the
experimental procedure to follow labelled IL-7 from the gut to
the lymphoid organs.
doi:10.1371/journal.pone.0020812.g002
Figure 3. IRDye800 labelled IL-7 introduced by gavage into the stomach of a mouse pup can be detected as green fluorescence in
the anterior mediastinum on the next day (A), as indicated by the white arrow. Labelled product is apparent also around the jaws of the
animal and in the intestine. The pup is in a prone position on the glass surface of the Odyssey and the image is from underneath. Two examples of
samples from quantitation studies are shown here where newborn pups were fed 100 ng of labelled protein, either rIL-7 (B,C) or albumin (D,E), and
culled after 24 hours and their thymus (B,D) and spleen (C,E) removed and scanned.
doi:10.1371/journal.pone.0020812.g003
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and was below the level of detection 8 days after birth (Fig 1). We
tested animals at both 14 and 18 days after birth but failed to
detect IL-7 in the milk in their stomachs at these times. We
validated the specificity of our assay by testing milk from IL-7
knock-out mice and found it to be negative and were further
concerned that the lL-7 we detected in milk was absorbed from the
plasma. This seemed unlikely because we could detect IL-7 in the
blood of these animals at weaning at an average of 13.6 ng/ml of
serum but were unable to detect any in the stomach at day 8 and
thereafter.
Tracing IL-7 movement from the gut
Whether the movement of IL-7 across the gut into the tissues
was feasible was tested by introducing recombinant murine IL-7
labelled with IRDye800 into the stomach of newborn mice and
tracing its movement as outlined (Fig 2). We following labelled IL-
7 in live mouse pups over time by imaging and our initial results
suggested that labelled IL-7 could traverse the gut and be
identified in the anterior mediastinum in a region where we
would expect to find the thymus (Fig 3A).
We were concerned that the fluorescence we were detecting in
the anterior mediastinum may have derived from label detaching
from the IL-7 and to test for this we fed mice either recombinant
mouse albumin labelled with IRDye 800 or recombinant mouse
IL-7 labelled with the same dye and imaged them over the same
time period. When we viewed their fluorescence our results
revealed that organs from animals fed labelled IL-7 were far
brighter than those fed labelled albumin (Fig 3B-E) suggesting that
the IRDye800 remained associated with the IL-7 after its passage
through the gut. To assess the percentage of IL-7 which travelled
from the gut to the lymphoid organs we fed 1 day old pups 100 ng
of labelled IL-7 and 24 hours later excised the thymus and the
spleens of these animals. To assess the amount of labelled protein
present in these tissues we digested the spleen and thymus from the
offspring with proteinase K and measured the fluorescence of the
solution, and compared it with our labelled IL-7 standard curve
(Fig 4a, b). From this we calculated that the thymus contained on
average 65pg (n= 11) whilst the spleen contained an average of
62pg (n= 12) of labelled IL-7 (Fig 4c).
Cross fostering experiments
Transmission across the gut does not necessarily imply that the
maternally-derived IL-7 would be functionally active in the
lymphoid tissue, so we sought to determine the contribution of
IL-7 in murine milk to T cell production and maintenance in the
offspring by analysing IL-7 knock out pups fostered onto wild type
dams (KORWT) and comparing them with IL-7 knock outs on
IL-7 knock out dams (KORKO), wild type on IL-7 knock outs
dams (WTRKO) and wild type on wild type dams (WTRWT).
Analysis of the subpopulations within the thymus (Table 1) showed
similar numbers of triple negative cells in KORWT, WTRKO
and WTRWT pups and these values were almost 3 times higher
than found in KORKO pups. Comparison of later stages in the
pathway showed a similar number of double positive and single
positive thymocytes in the KORKO and KORWT pups and
that these values were considerably less than in the WTRKO and
WTRWT pups.
Further analysis was undertaken within the triple negative
population to determine any differences and the results revealed
that there were more CD44+CD252 cells in the KORWT pups
(average of 5.056105) compared with the KORKO pups (average
of 1.56105), and the progeny of this population, the CD44+CD25+
cells showed significantly greater numbers in KORWT animals
compared with the KORKO pups (1.156105 versus 8.136104
p= 0.03 Fig 5).
To determine the effect of maternal IL-7 on peripheral T cell
populations we followed changes in the T cells in the spleens of our
KORWT and compared them with their KORKO and wild
type (WT) counterparts. The results reveal a significantly greater
percentage of CD3+ T cells in the spleens of KORWT than in the
KORKO pups and this translated into significantly greater T cell
Figure 4. Scan of 96 well plate containing digested tissues from
animals given labelled IL-7 and a serial dilution in quadrupli-
cate of labelled murine IL-7 seen in (A). Digested spleens are in
row F, wells 3 through 8, and digested thymus tissue is in row H, wells 3
through 8. Wells A–D in column 1 contains IL-7 at 10 ng in a total
volume of 50 ml and the subsequent columns (2 through 12) contain
doubling serial dilutions. The standard curve of recombinant CW800
labelled murine IL-7 (B) shows means6 1 standard deviation from
quadruplicate wells and the calculated amount of IL-7 in individual
spleens and thymuses, are seen in (C).
doi:10.1371/journal.pone.0020812.g004
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numbers (Table 2). Closer analysis of the subpopulations revealed
(Fig 6) that the KORWT pups contained significantly more
CD3+CD4+ T cells than the KORKO spleens (6.86105 vs
3.56105 p= 0.026).
Discussion
These results demonstrate that IL-7 is present in milk and
provide direct evidence that when transmitted to the offspring IL-7
can cross the gut and enter the tissues and impact on both T cell
production and T cell maintenance.
The detection of IL-7 in mouse milk mirrors previous human
studies [28,19] and the detection profile of IL-7 within the milk,
high after birth and then declining with time is similar to that
seen in our earlier human studies in The Gambia [19], and to
that reported for IL-18 [29]. The identification of IL-7 in
maternally derived milk posed the question of whether it could
be transported into the tissues to act systemically. Maturation of
the gastrointestinal tract is a dynamic process and at birth the
barrier function is still developing. The permeability of the gut
to macromolecules is a recognised phenomenon with evidence
from previous studies showing that intact large peptides present
in milk such as insulin or epidermal growth factor can cross the
intestinal barrier and enter the circulation of the offspring
[30,31].
Our initial profiles of the fluorescence distribution after feeding
tagged IL-7 suggest that the IL-7 could pass through the gut and
enter the tissues however these profiles could also be interpreted
as being due to the dissociation of the fluorescent tag from the IL-
7 molecule following acid or protease digestion. Secretion of acid
is initiated 4 days after birth in the mouse [32] whilst
enteropeptidases such as enterokinase are present on postnatal
days 2–6 albeit at low levels [33]. The neonates were fed labelled
IL-7 on the day after birth and so it seemed unlikely that
digestion or dissociation of the protein could be construed to
account for the fluorescence seen in the tissues. Moreover the
considerably reduced fluorescence seen when animals were fed
labelled recombinant murine albumin would also seem to support
this and discount the notion that the fluorescent profile we saw
was due to digestion of the protein and release of the fluorescent
tag.
The data from fluorescent analysis provides direct support for
the movement of IL-7 into the tissues, and further confirmation
that IL-7 could cross the gut and be functionally active in the
tissues came from analysis of lymphoid tissue in IL-7 knock out
pups fostered onto wild type dams at birth.
Table 1. Comparison of the numbers of cells in the major populations of the thymus in offspring and the effect of IL-7.
Condition n
Number of TN
thymocytes
(average ± 1SD)6106
Number of CD4+CD8+
thymocytes (average ± 1SD)
6107
Total number of CD4+CD82
thymocytes (average ±
1SD)6107
Total number of CD42CD8+
thymocytes (average ±
1SD)6106
KO to KO 18 0.8360.87 1.7361.48 0.3860.49 1.2361.8
KO to WT 18 2.3664.52 1.1460.49 0.7160.90 1.561.99
WT to KO 10 3.364.57 12.767.6 3.7761.73 11.1365.06
WT to WT 13 2.6261.33 8.566.7 1.461.0 3.8362.84
doi:10.1371/journal.pone.0020812.t001
Figure 5. In cross fostering experiments more CD44+CD252 and CD44+CD25+ thymocytes are found in the thymus of IL-7 knock out
animals fostered onto wild type animals (e) than those left with their IL-7 knock out mothers (n). Values are similar to those obtained
with wild type animals maintained on wild type mothers (m). Values which are significantly different (where p,0.05) from the knock out animals on
knock out mothers are indicated by the annotation.
doi:10.1371/journal.pone.0020812.g005
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Lymphocyte development and maintenance is severely com-
promised in IL-7 knockout mice which display severe lympho-
poenia with the spleen and thymus having less than 20% of the
cellularity of normal wild type controls [25]. In the thymus of
normal wild type animals the earliest precursors of the T cell
pathway are CD32CD4l|oCD8 [34] and differentiation stages
from these precursors can be discriminated on the basis of
expression of CD44 and CD25. Progress from the most immature
stage, CD44+CD252 requires the transient acquisition of CD25 so
the cell first becomes CD44+CD25+ before becoming
CD442CD25+ and then the loss of CD44 when the population
is CD442CD252 [35]. IL-7 has a crucial role in these early
developmental stages where it aids the survival of cells [36] and all
subsets express the IL-7 receptor but at different levels. Because
early stages in the intrathymic pathway show slightly higher levels
of expression of the IL-7 receptor than the later CD442 stages
[37] their enhanced survival may be favoured when IL-7 is limited
and this is reflected in the differences seen between the KO pups
on KO dams and those on WT dams. The increase in the number
of cells in the populations of these early stages of the T cell
pathway seen in the KO pups on WT dams compared with KO
pups on KO dams was noticeable and we considered sample bias
to be an unlikely contributor to this because for each condition we
analysed the results of several transfers.
Analysis of the T cells in the spleen was undertaken to confirm
whether there were any downstream effects on T cell develop-
ment. The significant increase in the number of T cells within the
CD4+ subset in the KO pups on WT dams compared with KO
pups on KO dams fits with previous work showing that the naive
CD4+ T cell population is the compartment easily perturbed by
abrogating IL-7–IL-7R interactions, which may be because this
population expresses a slightly higher level of IL-7R on the cell
surface than other peripheral T cell populations [38]. Our results
also fit with a previous study which noted that during the early
postnatal period recent thymic emigrants emerge into a lympho-
penic environment and undergo antigen independent proliferation
which is mainly restricted to CD4+ T cells [39].
The results from both the tracing experiments and the cross
fostering experiments together provide direct evidence that
maternally derived IL-7 impacts on the immune system in the
offspring. Breast feeding has been known to have a positive effect
on thymic size [40,15,41] in the offspring and our study indicates
that IL-7 in maternal milk contributes to this increased size. Both
thymic output and peripheral proliferation contribute to the
formation of the peripheral T cell pool [42,43] and since
proliferation expands only pre-existing peripheral T cells, greater
thymic output would indicate a broader repertoire in the
peripheral T cell pool. In addition to its effect on thymic size,
provision of IL-7 from maternal sources would assist the
proliferation of peripheral T cells. In adults the amount of
available IL-7 in the periphery has been considered to regulate the
size of the peripheral T cell pool, where its production by stromal
cells in lymphoid organs appears to be uninfluenced by extrinsic
stimuli [44]. The presence of maternally derived IL-7 will disturb
the equilibrium between overall T cell numbers and the fixed rate
of endogenous IL-7 production, introducing a bias towards the
Figure 6. In cross fostering experiments IL-7 knock out animals fostered onto wild type animals (e) had more CD3+ T cells and more
CD3+CD4+ T cells than those left with their IL-7 knock out mothers (n). Values are similar to those obtained with wild type animals
maintained on wild type mothers (m).Values which are significantly different (where p,0.05) from the knock out animals on knock out mothers are
indicated by the annotation.
doi:10.1371/journal.pone.0020812.g006
Table 2. Comparison of the numbers of cells in the spleen of
offspring and the effect of IL-7.
Condition
Percentage and No. (average ± 1SD6106)
of CD3+ cells in the spleen [n]
KO to KO 2% (0.5960.52) [9]
KO to WT 4% (1.0960.39) [10]
WT to KO 12% (11.866.69) [5]
WT to WT 15% (4.8663.26) [11]
doi:10.1371/journal.pone.0020812.t002
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production of more T cells and supporting the survival of a larger
peripheral T cell pool but only for a period limited both by the
permeability of the gut and the availability of IL-7 within breast
milk. High levels of IL-7 in milk in the period after birth when the
integrity of the gut is incomplete could benefit the offspring by
supporting the development and maintenance of a broad T cell
repertoire at a time when the antigen load of the external
environment increases substantially.
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